Preventing Spinal Infection: Ultrasound Triggered Prophylaxis

预防脊柱感染:超声触发预防

基本信息

  • 批准号:
    9233017
  • 负责人:
  • 金额:
    $ 48.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION: Despite aggressive peri-operative antibiotic treatments, between 1 in 20 and 1 in 100 patients undergoing spinal surgery develop an infection. For patients with traumatic injury, these rates easily exceed 10%. With > 5 million annual surgeries by 2030 and only partially effective infection treatments, the cost and disability due to infection will continue to mount. More effective means to prevent infection are therefore a clinical imperative. To be most effective, new treatments must eradicate pathogens before their adherence to the implant surface attenuates antibiotic and immune susceptibility. Aware of this requirement, our laboratories have long focused on new ways to create antibacterial implant systems that prevent bacterial colonization. Our hypothesis is that maintaining supra-therapeutic antibiotic concentrations at the hardware site during the peri-operative period will prevent establishment of infection and lower infection rates. To test this, we propose to develop a simple porous polyether ether ketone (PEEK) sheath that surrounds the spinal rod and releases its contents--mg quantities of a combination of antibiotics--upon application of ultrasound (US); all antibiotics will be released from sheaths during the peri-operative period to ensure aggressive prophylaxis. Use of antibiotic combinations is expected to minimize antibiotic resistant pathogens and to ensure that all contaminating pathogens are eradicated. There are three specific aims 1: To characterize the stability and release kinetics of an US-activated antimicrobial release system. 2: To test the ability of the sheaths to prevent bacterial colonization of adjacent hardware in vitro. 3: To determine the utility of the sheath in eradicating infection in an in vivo model of infection. The approach detailed in this application ensures eradication of pathogens in the immediate post-operative period. The concept and impetus has arisen through the efforts of a spinal surgeon, US physicist, basic scientist (implant infections), and biomaterials engineer (PEEK and implant retrieval and analysis). It directly addresses the problem of spinal implant infections using innovative applications of proven materials that upon completion of this project can quickly and effectively be translated to the clinical arena. We anticipate that this therapy wil further lower infection rates and ameliorate the pain, suffering, disability, and mortality associated with infections that occur after spinal surgery.
 产品说明:尽管积极的围手术期抗生素治疗,1/20至1/100的脊柱手术患者发生感染。对于创伤性损伤患者,这些比率很容易超过10%。到2030年,每年有超过500万例手术,只有部分有效的感染治疗,感染造成的费用和残疾将继续增加。 靴式.因此,更有效的预防感染的手段是临床上的当务之急。为了最有效,新的治疗方法必须在病原体粘附在植入物表面之前根除它们,从而削弱抗生素和免疫敏感性。意识到这一要求,我们的实验室长期以来一直专注于创造防止细菌定植的抗菌植入系统的新方法。我们的假设是,在围手术期内,在硬件部位保持超治疗抗生素浓度将防止感染的建立并降低感染率。为了测试这一点,我们建议开发一种简单的多孔聚醚醚酮(PEEK)鞘管,该鞘管围绕脊柱棒并在应用超声(US)时释放其内容物-mg量的抗生素组合;所有抗生素 将在围手术期从鞘管中释放,以确保积极的预防。抗生素组合的使用预计将最大限度地减少抗生素耐药病原体,并确保根除所有污染病原体。有三个具体目标1:表征US活化的抗菌剂释放系统的稳定性和释放动力学。2:测试鞘管在体外防止相邻硬件细菌定植的能力。3:确定鞘管在体内感染模型中根除感染的效用。本申请中详述的方法可确保在术后即刻根除病原体。通过脊柱外科医生、美国物理学家、基础科学家(植入物感染)和生物材料工程师(PEEK和植入物回收和分析)的努力,这一概念和动力已经出现。它直接解决了脊柱植入物感染的问题,使用经过验证的材料的创新应用,在完成该项目后,可以快速有效地转化为临床竞技场。我们预期这种疗法将进一步降低感染率,并改善脊柱手术后与感染相关的疼痛、痛苦、残疾和死亡率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Flemming Forsberg其他文献

Flemming Forsberg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Flemming Forsberg', 18)}}的其他基金

Vevo 3100 ultrasound scanner and PV loop system
Vevo 3100 超声波扫描仪和 PV 环路系统
  • 批准号:
    10177118
  • 财政年份:
    2021
  • 资助金额:
    $ 48.33万
  • 项目类别:
Prostate Cancer Diagnosis by Multiparametric Ultrasound
多参数超声诊断前列腺癌
  • 批准号:
    10472567
  • 财政年份:
    2020
  • 资助金额:
    $ 48.33万
  • 项目类别:
Prostate Cancer Diagnosis by Multiparametric Ultrasound
多参数超声诊断前列腺癌
  • 批准号:
    10199974
  • 财政年份:
    2020
  • 资助金额:
    $ 48.33万
  • 项目类别:
Prostate Cancer Diagnosis by Multiparametric Ultrasound
多参数超声诊断前列腺癌
  • 批准号:
    10032625
  • 财政年份:
    2020
  • 资助金额:
    $ 48.33万
  • 项目类别:
Optimizing Ultrasound Enhanced Delivery of Therapeutics
优化超声增强治疗的输送
  • 批准号:
    10217039
  • 财政年份:
    2016
  • 资助金额:
    $ 48.33万
  • 项目类别:
Optimizing Ultrasound Enhanced Delivery of Therapeutics
优化超声增强治疗的输送
  • 批准号:
    9337418
  • 财政年份:
    2016
  • 资助金额:
    $ 48.33万
  • 项目类别:
Optimizing Ultrasound Enhanced Delivery of Therapeutics
优化超声增强治疗的输送
  • 批准号:
    9185490
  • 财政年份:
    2016
  • 资助金额:
    $ 48.33万
  • 项目类别:
Preventing Spinal Infection: Ultrasound Triggered Prophylaxis
预防脊柱感染:超声触发预防
  • 批准号:
    9898313
  • 财政年份:
    2016
  • 资助金额:
    $ 48.33万
  • 项目类别:
Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging
用次谐波超声成像检测高级别前列腺癌
  • 批准号:
    9024279
  • 财政年份:
    2016
  • 资助金额:
    $ 48.33万
  • 项目类别:
Optimizing Ultrasound Enhanced Delivery of Therapeutics
优化超声增强治疗的输送
  • 批准号:
    10612329
  • 财政年份:
    2016
  • 资助金额:
    $ 48.33万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 48.33万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了